{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:51:10Z","timestamp":1789444270081,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T00:00:00Z","timestamp":1330128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10549-012-1991-y","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T08:25:07Z","timestamp":1330071907000},"page":"695-702","source":"Crossref","is-referenced-by-count":16,"title":["Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?"],"prefix":"10.1007","volume":"133","author":[{"given":"Tanya S.","family":"Berrang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lesperance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline T.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen H.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo A.","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,25]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1997.15.6.2345","volume":"15","author":"AE Giuliano","year":"1997","unstructured":"Giuliano AE, Jones RC, Brennan M et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345\u20132350","journal-title":"J Clin Oncol"},{"key":"1991_CR2","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703\u20137720","journal-title":"J Clin Oncol"},{"key":"1991_CR3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9610(98)00264-5","volume":"176","author":"IT Rubio","year":"1998","unstructured":"Rubio IT, Korourian S, Cowan C et al (1998) Sentinel lymph node biopsy for staging breast cancer. Am J Surg 176:532\u2013537","journal-title":"Am J Surg"},{"key":"1991_CR4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U Veronesi","year":"1997","unstructured":"Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864\u20131867","journal-title":"Lancet"},{"key":"1991_CR5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol 11:927\u2013933","journal-title":"Lancet Oncol"},{"key":"1991_CR6","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/archsurg.136.6.688","volume":"136","author":"VJ Kamath","year":"2001","unstructured":"Kamath VJ, Giuliano R, Dauway EL et al (2001) Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla. Arch Surg 136:688\u2013692","journal-title":"Arch Surg"},{"key":"1991_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11912-009-0004-8","volume":"11","author":"KM Erb","year":"2009","unstructured":"Erb KM, Julian TB (2009) Completion of axillary dissection for a positive sentinel node: necessary or not? Curr Oncol Rep 11:15\u201320","journal-title":"Curr Oncol Rep"},{"key":"1991_CR8","first-page":"166","volume":"165","author":"J Cantin","year":"2001","unstructured":"Cantin J, Scarth H, Levine M et al (2001) Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ 165:166\u2013173","journal-title":"CMAJ"},{"key":"1991_CR9","first-page":"28s","volume":"18s","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall LM, Beitsch PD et al (2010) ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1\u20132 N0 M0 breast cancer who have a positive sentinel node. J Clin Oncol 18s:28s (suppl; abstr CRA506)","journal-title":"J Clin Oncol"},{"key":"1991_CR10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000658-199904000-00013","volume":"229","author":"KU Chu","year":"1999","unstructured":"Chu KU, Turner RR, Hansen NM et al (1999) Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229:536\u2013541","journal-title":"Ann Surg"},{"key":"1991_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y","volume":"89","author":"RR Turner","year":"2000","unstructured":"Turner RR, Chu KU, Qi K et al (2000) Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574\u2013581","journal-title":"Cancer"},{"key":"1991_CR12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391\u2013401","journal-title":"Ann Surg"},{"key":"1991_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Eng J Med 347:567\u2013575","journal-title":"N Eng J Med"},{"key":"1991_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archsurg.138.1.52","volume":"138","author":"JM Guenther","year":"2003","unstructured":"Guenther JM, Hansen NM, DiFronzo LA et al (2003) Axillary dissection is not required for all patients with breast cancer and positive nodes. Arch Surg 138:52\u201356","journal-title":"Arch Surg"},{"key":"1991_CR15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. AMA 305:569\u2013575","journal-title":"AMA"},{"key":"1991_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0360-3016(00)00631-3","volume":"48","author":"S Galper","year":"2000","unstructured":"Galper S, Recht A, Silver B et al (2000) Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys 48:125\u2013132","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1991_CR17","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1016\/S0360-3016(01)02267-2","volume":"51","author":"A Takeda","year":"2001","unstructured":"Takeda A, Sigematsu N, Kondo M et al (2001) Radiotherapy after breast-conserving surgery without axillary dissection for T1\u20132, no breast cancer patients: comparison of the tangential and three-field irradiation technique. Int J Radiat Oncol Biol Phys 51(3):S243 (suppl 1)","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1991_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/bcr906","volume":"6","author":"EJ Rutgers","year":"2004","unstructured":"Rutgers EJ, Meijnen P, Bonnefoi H (2004) Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 6:165\u2013169","journal-title":"Breast Cancer Res"},{"key":"1991_CR19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1245\/s10434-010-0945-z","volume":"17","author":"ME Straver","year":"2010","unstructured":"Straver ME, Meijnen P, Van Tienhoven G et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981\u201322023 AMAROS trial. Ann Surg Oncol 17:1854\u20131861","journal-title":"Ann Surg Oncol"},{"key":"1991_CR20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2005.11.008","volume":"32","author":"JS Rietman","year":"2006","unstructured":"Rietman JS, Geertzen JH, Hoekstra HJ et al (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32:148\u2013152","journal-title":"Eur J Surg Oncol"},{"key":"1991_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3121\/cmr.1.4.309","volume":"1","author":"EP Mamounas","year":"2003","unstructured":"Mamounas EP (2003) NSABP breast cancer clinical trials: recent results and future directions. Clin Med Res 1:309\u2013326","journal-title":"Clin Med Res"},{"key":"1991_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546\u2013553","journal-title":"N Engl J Med"},{"key":"1991_CR23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/cncr.11545","volume":"98","author":"JS Rietman","year":"2003","unstructured":"Rietman JS, Dijkstra PU, Geertzen JH et al (2003) Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer 98:690\u2013696","journal-title":"Cancer"},{"key":"1991_CR24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599\u2013609","journal-title":"J Natl Cancer Inst"},{"key":"1991_CR25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","volume":"10","author":"KJ Zee Van","year":"2003","unstructured":"Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140\u20131151","journal-title":"Ann Surg Oncol"},{"key":"1991_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-8-66","volume":"8","author":"HE Kohrt","year":"2008","unstructured":"Kohrt HE, Olshen RA, Bermas HR et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66","journal-title":"BMC Cancer"},{"key":"1991_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","volume":"91","author":"E Barranger","year":"2005","unstructured":"Barranger E, Coutant C, Flahault A et al (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113\u2013119","journal-title":"Breast Cancer Res Treat"},{"key":"1991_CR28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","volume":"95","author":"A Pal","year":"2008","unstructured":"Pal A, Provenzano E, Duffy SW et al (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302\u2013309","journal-title":"Br J Surg"},{"key":"1991_CR29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjsurg.2005.06.008","volume":"190","author":"AC Degnim","year":"2005","unstructured":"Degnim AC, Reynolds C, Pantvaidya G et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543\u2013550","journal-title":"Am J Surg"},{"key":"1991_CR30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","volume":"26","author":"A Katz","year":"2008","unstructured":"Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node\u2014positive breast cancer. J Clin Oncol 26:2093\u20132098","journal-title":"J Clin Oncol"},{"key":"1991_CR31","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1742-1241.2008.01887.x","volume":"62","author":"B Unal","year":"2008","unstructured":"Unal B, Gur AS, Kayiran O et al (2008) Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Int J Clin Pract 62:1785\u20131791","journal-title":"Int J Clin Pract"},{"key":"1991_CR32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1245\/s10434-006-9223-5","volume":"14","author":"CE Dauphine","year":"2007","unstructured":"Dauphine CE, Haukoos JS, Vargas MP et al (2007) Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 14:1014\u20131019","journal-title":"Ann Surg Oncol"},{"key":"1991_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjsurg.2006.06.016","volume":"192","author":"MH Cripe","year":"2006","unstructured":"Cripe MH, Beran LC, Liang WC et al (2006) The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg 192:484\u2013487","journal-title":"Am J Surg"},{"key":"1991_CR34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/000313480407001119","volume":"70","author":"L Kocsis","year":"2004","unstructured":"Kocsis L, Svebis M, Boross G et al (2004) Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 70:1019\u20131024","journal-title":"Am Surg"},{"key":"1991_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1245\/ASO.2006.03.078","volume":"13","author":"LA Lambert","year":"2006","unstructured":"Lambert LA, Ayers GD, Hwang RF et al (2006) Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13:310\u2013320","journal-title":"Ann Surg Oncol"},{"key":"1991_CR36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1245\/ASO.2005.07.022","volume":"12","author":"ML Smidt","year":"2005","unstructured":"Smidt ML, Kuster DM, van der Wilt GJ et al (2005) Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 12:1066\u20131072","journal-title":"Ann Surg Oncol"},{"key":"1991_CR37","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jso.20835","volume":"96","author":"J Zgajnar","year":"2007","unstructured":"Zgajnar J, Perhavec A, Hocevar M et al (2007) Low performance of the MSKCC nomogram in preoperatively ultrasonically negative axillary lymph node in breast cancer patients. J Surg Oncol 96:547\u2013553","journal-title":"J Surg Oncol"},{"key":"1991_CR38","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1245\/s10434-006-9331-2","volume":"14","author":"S Alran","year":"2007","unstructured":"Alran S, De Rycke Y, Fourchotte V et al (2007) Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14:2195\u20132201","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"1991_CR39","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","volume":"27","author":"C Coutant","year":"2009","unstructured":"Coutant C, Olivier C, Lambaudie E et al (2009) Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 27(17):2800\u20132808","journal-title":"J Clin Oncol"},{"key":"1991_CR40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1245\/s10434-009-0359-y","volume":"16","author":"RFD Parra","year":"2009","unstructured":"Parra RFD, Ernst MF, Bevilacqua JLB et al (2009) Validation of a nomogram to predict the risk of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 16:1128\u20131135","journal-title":"Ann Surg Oncol"},{"key":"1991_CR41","unstructured":"R Development Core Team (2010) R: a language and environment for statistical computing. Vienna, http:\/\/www.R-project.org . Accessed November 2010"},{"key":"1991_CR42","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies","author":"F Harrell","year":"2001","unstructured":"Harrell F (2001) Regression modeling strategies. Springer, New York"},{"key":"1991_CR43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet Oncol 8:881\u2013888","journal-title":"Lancet Oncol"},{"issue":"4","key":"1991_CR44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9610(00)00466-9","volume":"180","author":"L Tafra","year":"2000","unstructured":"Tafra L, McMasters K, Whitworth P et al (2000) Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 180(4):268\u2013273","journal-title":"Am J Surg"},{"key":"1991_CR45","author":"G Houvenaeghel","year":"2011","unstructured":"Houvenaeghel G, Bannier M, Nos C et al (2011) Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: nomogram validation and comparison with other models. The Breast. doi: 10.1016\/j.breast.2011.09.013","journal-title":"The Breast"},{"key":"1991_CR46","unstructured":"American Society of Clinical Oncology: ASCO perspective on JAMA breast cancer lymph node study findings http:\/\/www.asco.org\/ascov2\/Department%20Content\/Cancer%20Policy%20and%20Clinical%20Affairs\/Downloads\/ASCO%20Perspective%20on%20JAMA%20Breast%20Cancer%20Lymph%20Node%20Study%20Findings.pdf . February 17, 2011"},{"issue":"18","key":"1991_CR47","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1245\/s10434-011-1593-7","volume":"9","author":"AS Caudle","year":"2011","unstructured":"Caudle AS, Hunt KK, Kuerer HM et al (2011) Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 9(18):2407\u20132412","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1991_CR48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2011.131","volume":"305","author":"GW Carlson","year":"2011","unstructured":"Carlson GW, Wood WC (2011) Management of axillary lymph node metastasis in breast cancer: making progress. JAMA 305(6):606\u2013607","journal-title":"JAMA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-1991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-012-1991-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-012-1991-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:39:44Z","timestamp":1687279184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-012-1991-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,25]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s10549-012-1991-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,25]]}}}